% | $
Quotes you view appear here for quick access.

Inovio Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • joynlight77 joynlight77 Oct 15, 2012 10:28 AM Flag

    Inovio Pharmaceuticals' Cancer Vaccine Demonstrates for 1st Time that a DNA-Based Therapeutic Vaccine Can Produce Immune Responses to Kill Target Cells

    I highly recommend investors look into another very promising company using similar electroporation technology with proven results: ONCOSEC MEDICAL (ONCS) . Both companies share similarities and yield results.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • actually, ONCS was granted a license to use Inovio's technology. They just paid Inovio 500k in September and owe additional payments of 1 mil next March & 1 mil in December 2013.....but I agree ONCS is worth a watch...

      Sentiment: Buy

10.61-0.08(-0.75%)May 27 4:00 PMEDT